



Healthcare | Mid Cap
Narayana Hrudayalaya Ltd displays a mixed financial profile. Profitability and coverage ratios are strong, reflecting efficient operations and ability to meet obligations. Efficiency ratios also indicate effective management of inventory and receivables. However, liquidity is a concern, with current and cash ratios suggesting potential short-term challenges. Growth metrics are inconsistent, with strong revenue and asset growth offset by declines in EPS and net income growth. Financial ratios are weak, particularly regarding book value per share and capital expenditures. Overall, the company shows promise in profitability and operational efficiency but needs to address liquidity and inconsistent growth to ensure long-term financial stability.
Narayana Hrudayalaya Ltd displays a mixed financial profile. Profitability and coverage ratios are strong, reflecting efficient operations and ability to meet obligations. Efficiency ratios also indicate effective management of inventory and receivables. However, liquidity is a concern, with current and cash ratios suggesting potential short-term challenges. Growth metrics are inconsistent, with strong revenue and asset growth offset by declines in EPS and net income growth. Financial ratios are weak, particularly regarding book value per share and capital expenditures. Overall, the company shows promise in profitability and operational efficiency but needs to address liquidity and inconsistent growth to ensure long-term financial stability.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
78.74
Industry Median
25.09
Mid Cap Median
34.76
P/E RATIO
49.18
P/B RATIO
8.73
Industry Median
2.00
Mid Cap Median
5.29
P/S RATIO
5.10
Industry Median
5.48
Mid Cap Median
6.16
Others
PEG RATIO
0.00
EV/EBITDA RATIO
26.46
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1938.7 as on Sep 1, 2026.
The company's growth trajectory is inconsistent. While revenue and asset growth rates are strong, indicating business expansion, declines in EPS and net income growth raise concerns about profitability. This suggests that the company needs to focus on improving its bottom-line performance to sustain long-term growth.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 43.28 | 22.26 | 8.07 | 12.13 | 44.01 |
| Operating Profit Growth Rate | 251.32 | 48.64 | 18.34 | 11.13 | 24.11 |
| Earnings Per Share (EPS) Growth | 2490 | 77.35 | 30.17 | 0.1 | 1.97 |
| Asset Growth Rate | 13.1 | 32.68 | 35.08 | 29.08 | 71.56 |
| Net Income Growth Rate | 2542.86 | 77.49 | 30.15 | 0.13 | 1.9 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Concall Report⬤24th Feb 26
Q3 FY26 Earnings Conference Call
BULLISH SENTIMENT
No Stock News Available at This Moment.
Narayana Hrudayalaya Ltd. (NH) is a leading Indian healthcare provider, operating a chain of multi-specialty, tertiary care hospitals. Founded by renowned cardiac surgeon Dr. Devi Shetty, NH focuses on delivering high-quality, affordable healthcare across various disciplines like cardiac sciences, oncology, and neurology. It serves a wide patient base, solidifying its position among India's largest hospital networks.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Narayana Hrudayalaya Ltd's P/E ratio (TTM) is 78.74, compared to the industry median of 25.09 and large cap median of 34.76.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Narayana Hrudayalaya Ltd's P/B ratio is 8.73, compared to the industry median of 2.00 and large cap median of 5.29.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Narayana Hrudayalaya Ltd's P/S ratio is 5.10, compared to the industry median of 5.48 and large cap median of 6.16.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Narayana Hrudayalaya Ltd's PEG ratio is 1.50.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Narayana Hrudayalaya Ltd's EV/EBITDA ratio is 26.46.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Narayana Hrudayalaya Ltd's ROE is 17.77%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Narayana Hrudayalaya Ltd's ROA is 12.91%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Narayana Hrudayalaya Ltd's ROCE is 15%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Narayana Hrudayalaya Ltd's operating margin is 20.40%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Narayana Hrudayalaya Ltd's net margin is 10.21%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Narayana Hrudayalaya Ltd's current ratio is 1.67.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Narayana Hrudayalaya Ltd's debt-to-equity ratio is 1.22.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Narayana Hrudayalaya Ltd's interest coverage ratio is 4.95.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Narayana Hrudayalaya Ltd's DPS is ₹4.34.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Narayana Hrudayalaya Ltd's EPS is 1.97.
(Source line: "Ratios as of 01 Sept 2026, based on last traded price of ₹1938.70. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2000 (as Narayana Hrudayalaya Private Limited)
Headquarters: Bengaluru, Karnataka
Core Offerings: Multi-specialty Hospital Services, Cardiac Sciences, Oncology, Neurology, Gastroenterology
Stock Listing: NSE (NH), BSE (539551)
Promoter: Dr. Devi Prasad Shetty & Family
Narayana Hrudayalaya Private Limited was incorporated in 2000 by Dr. Devi Shetty, opening its first hospital in Bengaluru with a focus on affordable cardiac care. The company expanded rapidly across India, establishing a network of multi-specialty hospitals, heart centers, and cancer centers. It was publicly listed on Indian stock exchanges in 2016 and continues to grow its presence both domestically and internationally, upholding its founding vision of accessible, high-quality healthcare.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Hospital Services | Approx. 100% | Operating Profit |
Hospital Services: Operates a chain of multi-specialty, tertiary, and primary healthcare facilities across India and the Caribbean, including super-specialty hospitals, heart centers, and cancer treatment units.
Clinical Expertise: Renowned for its advanced capabilities in complex medical procedures, particularly in cardiac sciences, organ transplants, neurosciences, and oncology, serving a diverse patient base.
Diagnostic & Pharmacy Services: Provides comprehensive in-house diagnostic facilities and integrated pharmacy services across its hospital network, ensuring seamless patient care and convenience.
Healthcare Education & Research: Engages in medical education, training programs, and clinical research initiatives to foster medical talent and contribute to advancements in healthcare.
Dr. Devi Prasad Shetty - Chairman and Founder. A globally acclaimed cardiac surgeon and philanthropist, he established Narayana Health with a pioneering vision to make high-quality, affordable healthcare universally accessible. Dr. Emmanuel Rupert - Managing Director & Group CEO. A seasoned healthcare administrator, he oversees the company's strategic growth, operational excellence, and expansion initiatives.
Narayana Hrudayalaya Surgical Hospital Private Limited
Narayana Hrudayalaya Medical Hospital Private Limited
Narayana Hrudayalaya Healthcare Private Limited
Narayana Vaishnavi Hospitals Private Limited
Health City Cayman Islands Ltd.
Initial Public Offering (IPO) in 2016. No major recent bonus or rights issues. Involved in strategic acquisitions for network expansion, such as the acquisition of a hospital unit from NewRise Healthcare Pvt. Ltd.
The Narayana Hrudayalaya Ltd share price today is ₹1938.70 on NSE (NH), as of 12 Sept 2026.
As of 01 Sept 2026, Narayana Hrudayalaya Ltd share price is ₹1938.70, with previous close ₹1938.70. Today's range is ₹1938.70 to ₹1938.70. The 52-week range is ₹1938.70 to ₹1938.70.
As of today, Narayana Hrudayalaya Ltd's market cap is ₹40,286.19 crore (Large Cap).
Narayana Hrudayalaya Ltd's current P/E ratio is 78.74, compared to the UTILITIES sector average of 59.50.
Narayana Hrudayalaya Ltd's current P/B ratio is 8.73.
Narayana Hrudayalaya Ltd's current dividend yield is 0.22%. Last dividend of ₹0.80 per share was declared on 19-Feb-2024.
Narayana Hrudayalaya Ltd's EPS (TTM) is ₹1.97.
Narayana Hrudayalaya Ltd. (NH) is a leading Indian healthcare provider, operating a chain of multi-specialty, tertiary care hospitals. Founded by renowned cardiac surgeon Dr. Devi Shetty, NH focuses on delivering high-quality, affordable healthcare across various disciplines like cardiac sciences, oncology, and neurology. It serves a wide patient base, solidifying its position among India's largest hospital networks.
Narayana Hrudayalaya Ltd is promoted by Dr. Devi Prasad Shetty & Family, holding 63.27% as of 01 Sept 2026.
Narayana Hrudayalaya Ltd is listed on NSE (NH) and BSE (539551). Its next quarterly results are expected on August 2024.